Insider Trading & Ownership of Cedrik Michael Britten

Location
Tubingen
Summary
The estimated net worth of Cedrik Michael Britten is at least $2,475 dollars as of 18 Mar 2026. Cedrik Michael Britten is the Chief Medical Officer of Immatics N.V. and owns shares of Immatics N.V. (IMTX) stock worth about $2.5K.
Signature
/s/ Edward Sturchio, attorney-in-fact for Cedrik Michael Britten
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Cedrik Michael Britten and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Cedrik Michael Britten has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $2,475.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Immatics N.V. ($2,475).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Cedrik Michael Britten

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMTX Immatics N.V. Chief Medical Officer $2,475 18 Mar 2026

Insider Transactions Reported by Cedrik Michael Britten:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .